{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T04:47:39Z","timestamp":1770007659702,"version":"3.49.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1038\/ncpendmet0265","type":"journal-article","created":{"date-parts":[[2006,9,7]],"date-time":"2006-09-07T09:57:23Z","timestamp":1157623043000},"page":"494-503","source":"Crossref","is-referenced-by-count":82,"title":["The diagnosis and management of asymptomatic primary hyperparathyroidism"],"prefix":"10.1038","volume":"2","author":[{"given":"Shonni J","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpendmet0265_CR1","volume-title":"The Parathyroid Glands and Metabolic Bone Disease","author":"F Albright","year":"1948","unstructured":"Albright F and Reifenstein EC (1948) The Parathyroid Glands and Metabolic Bone Disease. Baltimore: Williams and Wilkins"},{"key":"BFncpendmet0265_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1056\/NEJM198001243020402","volume":"302","author":"H Heath","year":"1980","unstructured":"Heath H et al. (1980) Primary hyperparathyroidism incidence, morbidity and potential economic impact in a community. N Eng J Med 302: 189\u2013193","journal-title":"N Eng J Med"},{"key":"BFncpendmet0265_CR3","doi-asserted-by":"crossref","unstructured":"Silverberg SJ and Bilezikian JP (2001) Clinical presentation of primary hyperparthyroidism in the United States. In The Parathyroids, edn 2, 349\u2013360 (Eds Bilezikian JP et al.) New York: Academic Press","DOI":"10.1016\/B978-012098651-4\/50022-5"},{"key":"BFncpendmet0265_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0002-9343(99)00294-6","volume":"107","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg SJ et al. (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107: 561\u2013567","journal-title":"Am J Med"},{"key":"BFncpendmet0265_CR5","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1210\/jc.2002-021266","volume":"88","author":"SJ Silverberg","year":"2003","unstructured":"Silverberg SJ et al. (2003) Clinical utility of an immunoradiometric assay for whole PTH (1\u201384) in primary hyperparathyroidism. J Clin Endocrinol Metab 88: 4725\u20134730","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR6","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1210\/jc.2003-031014","volume":"88","author":"SJ Silverberg","year":"2003","unstructured":"Silverberg SJ and Bilezikian JP (2003) \u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease. J Clin Endocrinol Metab 88: 5348\u20135352","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR7","doi-asserted-by":"crossref","unstructured":"Shane E (2001) Parathyroid carcinoma. In The Parathyroids, edn 2, 515\u2013526 (Eds Bilezikian JP et al.) New York: Academic Press","DOI":"10.1016\/B978-012098651-4\/50035-3"},{"issue":"Suppl 2","key":"BFncpendmet0265_CR8","first-page":"N30","volume":"17","author":"A Arnold","year":"2002","unstructured":"Arnold A et al. (2002) Molecular pathogenesis of primary hyperparathyroidism. J Bone Miner Res 17 (Suppl 2): N30\u2013N36","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR9","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1172\/JCI114114","volume":"83","author":"A Arnold","year":"1989","unstructured":"Arnold A et al. (1989) Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in parathyroid adenoma. J Clin Invest 83: 2034\u20132040","journal-title":"J Clin Invest"},{"key":"BFncpendmet0265_CR10","first-page":"2627","volume":"83","author":"F Farnebo","year":"1998","unstructured":"Farnebo F et al. (1998) Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab 83: 2627\u20132630","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR11","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1359\/jbmr.1999.14.6.878","volume":"14","author":"F Cetani","year":"1999","unstructured":"Cetani F et al. (1999) No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J Bone Miner Res 14: 878\u2013882","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR12","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM et al. (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Eng J Med 349: 1722\u20131729","journal-title":"N Eng J Med"},{"key":"BFncpendmet0265_CR13","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD et al. (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32: 676\u2013680","journal-title":"Nat Genet"},{"key":"BFncpendmet0265_CR14","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1210\/jc.2005-0717","volume":"90","author":"LJ Krebs","year":"2005","unstructured":"Krebs LJ et al. (2005) HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab 90: 5015\u20135017","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR15","doi-asserted-by":"crossref","unstructured":"Mithal A et al. (2001) Clinical presentation of primary hyperparthyroidism: India, Brazil and China. In The Parathyroids, edn 2, 375\u2013386 (Eds Bilezikian JP et al.) New York: Academic Press","DOI":"10.1016\/B978-012098651-4\/50024-9"},{"key":"BFncpendmet0265_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jbmr.5650040302","volume":"4","author":"SJ Silverberg","year":"1989","unstructured":"Silverberg SJ et al. (1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4: 283\u2013291","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR17","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1210\/jcem-70-4-930","volume":"70","author":"MV Parisien","year":"1990","unstructured":"Parisien MV et al. (1990) The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure. J Clin Endocrinol Metab 70: 930\u2013938","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR18","first-page":"4007","volume":"81","author":"SJ Silverberg","year":"1996","unstructured":"Silverberg SJ et al. (1996) Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81: 4007\u20134012","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR19","first-page":"1562","volume":"84","author":"DW Dempster","year":"1999","unstructured":"Dempster DW (1999) On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84: 1562\u20131566","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S8756-3282(98)00042-8","volume":"22","author":"S Adami","year":"1998","unstructured":"Adami S et al. (1998) Bone measurements in primary hyperparathyroidism. Bone 22: 565\u2013570","journal-title":"Bone"},{"key":"BFncpendmet0265_CR21","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1359\/jbmr.2002.17.10.1741","volume":"17","author":"AM Parfitt","year":"2003","unstructured":"Parfitt AM (2003) Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 17: 1741\u20131743","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/bmj.321.7261.598","volume":"321","author":"P Vestergaard","year":"2000","unstructured":"Vestergaard P et al. (2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321: 598\u2013602","journal-title":"BMJ"},{"key":"BFncpendmet0265_CR23","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1359\/jbmr.1999.14.10.1700","volume":"14","author":"S Khosla","year":"1999","unstructured":"Khosla S et al. (1999) Primary hyperparathyroidism and the risk of fracture: a population based study. J Bone Miner Res 14: 1700\u20131707","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.7326\/0003-4819-109-12-959","volume":"109","author":"RJ Wilson","year":"1988","unstructured":"Wilson RJ et al. (1988) Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Ann Intern Med 109: 959\u2013962","journal-title":"Ann Intern Med"},{"key":"BFncpendmet0265_CR25","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","volume":"341","author":"SJ Silverberg","year":"1999","unstructured":"Silverberg SJ et al. (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341: 1249\u20131255","journal-title":"N Engl J Med"},{"key":"BFncpendmet0265_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0002-9343(90)90346-F","volume":"89","author":"SJ Silverberg","year":"1990","unstructured":"Silverberg SJ et al. (1990) Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 89: 327\u2013334","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"BFncpendmet0265_CR27","first-page":"N87","volume":"17","author":"M Peacock","year":"2002","unstructured":"Peacock M (2002) Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res 17 (Suppl 2): N87\u2013N94","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR28","first-page":"75","volume-title":"Cardiac Electrophysiology","author":"R Tsien","year":"1990","unstructured":"Tsien R (1990) Calcium channels in the cardiovascular system. In Cardiac Electrophysiology, 75\u201390 (Eds Rosen M et al.) Mt Kisco: Futura"},{"key":"BFncpendmet0265_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/hrt.54.5.539","volume":"54","author":"C Symons","year":"1985","unstructured":"Symons C et al. (1985) Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism\u2014an association. Br Heart J 54: 539\u2013542","journal-title":"Br Heart J"},{"key":"BFncpendmet0265_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0002-9343(81)90163-7","volume":"71","author":"WC Roberts","year":"1981","unstructured":"Roberts WC and Waller BF (1981) Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am J Med 71: 371\u2013384","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"BFncpendmet0265_CR31","first-page":"N117","volume":"17","author":"SJ Silverberg","year":"2002","unstructured":"Silverberg SJ (2002) Non-classical target organs in hyperparathyroidism. J Bone Miner Res 17 (Suppl 2): N117\u2013N125","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1365-2362.1998.00289.x","volume":"28","author":"A Hedback G and Oden","year":"1998","unstructured":"Hedback G and Oden A (1998) Increased risk of death from PHPT\u2014an update. Eur J Clin Invest 28: 271\u2013276","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 2","key":"BFncpendmet0265_CR33","first-page":"N68","volume":"17","author":"IL Nilsson","year":"2002","unstructured":"Nilsson IL et al. (2002) Clinical presentation of PHPT in Europe\u2014nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 17 (Suppl 2): N68\u2013N74","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00268-002-6589-9","volume":"27","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard P et al. (2003) Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 27: 216\u2013222","journal-title":"World J Surg"},{"key":"BFncpendmet0265_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","volume":"104","author":"RA Wermers","year":"1998","unstructured":"Wermers RA et al. (1998) Survival after diagnosis of PHPT: a population based study. Am J Med 104: 115\u2013122","journal-title":"Am J Med"},{"key":"BFncpendmet0265_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1055\/s-0029-1210507","volume":"86","author":"PD Broulik","year":"1985","unstructured":"Broulik PD et al. (1985) Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy. Exp Clin Endocrinol 86: 346\u2013352","journal-title":"Exp Clin Endocrinol"},{"key":"BFncpendmet0265_CR37","first-page":"569","volume":"49","author":"JO Bradley EL and Wells","year":"1983","unstructured":"Bradley EL and Wells JO (1983) Primary hyperparathyroidism and hypertension. Am Surg 49: 569\u2013570","journal-title":"Am Surg"},{"key":"BFncpendmet0265_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0002-9343(93)90260-V","volume":"95","author":"T Stefenelli","year":"1993","unstructured":"Stefenelli T et al. (1993) Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 95: 197\u2013202","journal-title":"Am J Med"},{"key":"BFncpendmet0265_CR39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1210\/jcem.82.1.3666","volume":"82","author":"T Stefenelli","year":"1997","unstructured":"Stefenelli T et al. (1997) Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 82: 106\u2013112","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1365-2265.1999.00651.x","volume":"50","author":"A Piovesan","year":"1999","unstructured":"Piovesan A et al. (1999) Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 50: 321\u2013328","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0265_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1067\/msy.2001.118368","volume":"130","author":"IL Nilsson","year":"2001","unstructured":"Nilsson IL et al. (2001) Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 130: 986\u2013990","journal-title":"Surgery"},{"key":"BFncpendmet0265_CR42","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1067\/msy.2099.101422","volume":"126","author":"IL Nilsson","year":"1999","unstructured":"Nilsson IL et al. (1999) Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126: 1049\u20131055","journal-title":"Surgery"},{"key":"BFncpendmet0265_CR43","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0008-6363(98)00177-1","volume":"40","author":"TR Neunteufl","year":"1998","unstructured":"Neunteufl TR (1998) Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 40: 396\u2013401","journal-title":"Cardiovasc Res"},{"key":"BFncpendmet0265_CR44","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1210\/jcem.85.10.6880","volume":"85","author":"JC Smith","year":"2000","unstructured":"Smith JC et al. (2000) Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 85: 3515\u20133519","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR45","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1210\/jc.2004-1400","volume":"90","author":"MR Rubin","year":"2005","unstructured":"Rubin MR et al. (2005) Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab 90: 3326\u20133330","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR46","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/0003-4819-80-2-182","volume":"80","author":"BM Patten","year":"1974","unstructured":"Patten BM et al. (1974) The neuromuscular disease of hyperparathyroidism. Ann Intern Med 80: 182\u2013194","journal-title":"Ann Intern Med"},{"key":"BFncpendmet0265_CR47","first-page":"143","volume":"74","author":"CT Vicale","year":"1949","unstructured":"Vicale CT (1949) Diagnostic features of muscular syndrome resulting from hyperparathyroidism, osteomalacia owing to renal tubular acidosis and perhaps to related disorders of calcium metabolism. Trans Am Neurol Assoc 74: 143\u2013147","journal-title":"Trans Am Neurol Assoc"},{"key":"BFncpendmet0265_CR48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0002-9343(89)80613-8","volume":"87","author":"SA Turken","year":"1989","unstructured":"Turken SA et al. (1989) Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 87: 553\u2013557","journal-title":"Am J Med"},{"key":"BFncpendmet0265_CR49","first-page":"947","volume":"116","author":"OH Clark","year":"1994","unstructured":"Clark OH (1994) \u201cAsymptomatic\u201d primary hyperparathyroidism: is parathyroidectomy indicated? Surgery 116: 947\u2013953","journal-title":"Surgery"},{"key":"BFncpendmet0265_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s002689900428","volume":"22","author":"JL Pasieka","year":"1998","unstructured":"Pasieka JL and Parsons L (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22: 513\u2013519","journal-title":"World J Surg"},{"key":"BFncpendmet0265_CR51","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0039-6060(99)70224-2","volume":"125","author":"RE Burney","year":"1999","unstructured":"Burney RE et al. (1999) Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 125: 608\u2013614","journal-title":"Surgery"},{"key":"BFncpendmet0265_CR52","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1067\/msy.2000.110844","volume":"128","author":"GB Talpos","year":"2000","unstructured":"Talpos GB et al. (2000) Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: Patient description and effects on the SF-36 health survey. Surgery 128: 1013\u20131020","journal-title":"Surgery"},{"key":"BFncpendmet0265_CR53","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0039-6060(03)00316-7","volume":"134","author":"RM Quiros","year":"2003","unstructured":"Quiros RM et al. (2003) Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134: 675\u2013681","journal-title":"Surgery"},{"key":"BFncpendmet0265_CR54","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2265.2004.02180.x","volume":"62","author":"CY Chiang","year":"2005","unstructured":"Chiang CY et al. (2005) A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients. Clin Endocrinol (Oxf) 62: 99\u2013104","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFncpendmet0265_CR55","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1365-2796.1998.00281.x","volume":"243","author":"RT Jensen","year":"1998","unstructured":"Jensen RT (1998) Management of the Zollinger\u2013Ellison syndrome in patients with multiple endocrine neoplasia type 1. J Int Med 243: 477\u2013488","journal-title":"J Int Med"},{"key":"BFncpendmet0265_CR56","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML et al. (2001) Consensus Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658\u20135671","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR57","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/jama.1980.03300290028015","volume":"243","author":"MA Bess","year":"1980","unstructured":"Bess MA et al. (1980) Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 243: 246\u2013247","journal-title":"JAMA"},{"key":"BFncpendmet0265_CR58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02787530","volume":"24","author":"Y Kondo","year":"1998","unstructured":"Kondo Y et al. (1998) Primary hyperparathyroidism and acute pancreatitis during pregnancy. Int J Pancreatol 24: 43\u201347","journal-title":"Int J Pancreatol"},{"issue":"Suppl 2","key":"BFncpendmet0265_CR59","first-page":"N2","volume":"17","author":"JP Bilezikian","year":"2002","unstructured":"Bilezikian JP et al. (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17 (Suppl 2): N2\u2013N11","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0002-9343(02)01306-2","volume":"113","author":"SJ Silverberg","year":"2002","unstructured":"Silverberg SJ et al. (2002) Youthfulness as a criterion for surgery in primary hyperparathyroidism. Am J Med 113: 681\u2013684","journal-title":"Am J Med"},{"key":"BFncpendmet0265_CR61","first-page":"1","volume":"389","author":"A Alveryd","year":"1968","unstructured":"Alveryd A (1968) Parathyroid glands in thyroid surgery. I. Anatomy of parathyroid glands. II. Postoperative hypoparathyroidism\u2014identification and autotransplantation of parathyroid glands. Acta Chir Scand 389: 1\u2013120","journal-title":"Acta Chir Scand"},{"key":"BFncpendmet0265_CR62","first-page":"14","volume":"95","author":"G Akerstrom","year":"1984","unstructured":"Akerstrom G et al. (1984) Surgical anatomy of human parathyroid glands. Surgery 95: 14\u201321","journal-title":"Surgery"},{"key":"BFncpendmet0265_CR63","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00000658-197603000-00010","volume":"183","author":"CA Wang","year":"1976","unstructured":"Wang CA (1976) The anatomic basis of parathyroid surgery. Ann Surg 183: 271\u2013275","journal-title":"Ann Surg"},{"key":"BFncpendmet0265_CR64","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/00000658-199405000-00014","volume":"219","author":"JP Wei","year":"1994","unstructured":"Wei JP et al. (1994) Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans. Ann Surg 219: 568\u2013572","journal-title":"Ann Surg"},{"key":"BFncpendmet0265_CR65","first-page":"1583","volume-title":"Endocrinology","author":"JA Norton","year":"2006","unstructured":"Norton JA (2006) Surgical management of hyperparathyroidism. In Endocrinology, edn 5 (vol 2), 1583\u20131594 (Eds DeGroot LJ and Jameson JL) Philadelphia: WB Saunders"},{"key":"BFncpendmet0265_CR66","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/BF03347248","volume":"28","author":"JB Ogilvie","year":"2005","unstructured":"Ogilvie JB and Clark OH (2005) Parathyroid surgery: we still need traditional and selective approaches. J Endocrinol Invest 28: 566\u2013569","journal-title":"J Endocrinol Invest"},{"key":"BFncpendmet0265_CR67","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/BF03347249","volume":"28","author":"P Miccoli","year":"2005","unstructured":"Miccoli P (2005) Parathyroid surgery: we only need a minimal surgical approach. J Endocrinol Invest 28: 570\u2013573","journal-title":"J Endocrinol Invest"},{"key":"BFncpendmet0265_CR68","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/00000658-200205000-00008","volume":"235","author":"R Udelsman","year":"2002","unstructured":"Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235: 665\u2013672","journal-title":"Ann Surg"},{"key":"BFncpendmet0265_CR69","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1097\/00000658-199906000-00015","volume":"229","author":"GL Irvin III","year":"1999","unstructured":"Irvin GL III et al. (1999) Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 229: 874\u2013878","journal-title":"Ann Surg"},{"key":"BFncpendmet0265_CR70","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.surg.2005.06.046","volume":"138","author":"H Chen","year":"2005","unstructured":"Chen H et al. (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138: 583\u2013587","journal-title":"Surgery"},{"key":"BFncpendmet0265_CR71","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00000658-198010000-00003","volume":"192","author":"SA Wells Jr","year":"1980","unstructured":"Wells SA Jr et al. (1980) Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg 192: 451\u2013458","journal-title":"Ann Surg"},{"key":"BFncpendmet0265_CR72","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0002-9343(97)00053-3","volume":"102","author":"FG Locker","year":"1997","unstructured":"Locker FG et al. (1997) Optimal dietary calcium intake in primary hyperparathyroidism. Am J Med 102: 543\u2013550","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"BFncpendmet0265_CR73","first-page":"N146","volume":"17","author":"R Marcus","year":"2002","unstructured":"Marcus R (2002) The role of estrogens and related compounds in the management of primary hyperparathyroidism. J Bone Min Res 17 (Suppl 2): N146\u2013N149","journal-title":"J Bone Min Res"},{"key":"BFncpendmet0265_CR74","doi-asserted-by":"publisher","first-page":"360","DOI":"10.7326\/0003-4819-125-5-199609010-00002","volume":"125","author":"AB Grey","year":"1996","unstructured":"Grey AB et al. (1996) Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. Ann Intern Med 125: 360\u2013368","journal-title":"Ann Intern Med"},{"key":"BFncpendmet0265_CR75","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1210\/jc.2002-020667","volume":"88","author":"MA Rubin","year":"2003","unstructured":"Rubin MA et al. (2003) Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 88: 1174\u20131178","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR76","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1210\/jc.2001-010385","volume":"87","author":"CR Parker","year":"2002","unstructured":"Parker CR et al. (2002) Alendronate in the treatment of primary hyperparathyroidism-related osteoporosis: a 2-year study. J Clin Endocrinol Metab 87: 4482\u20134489","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR77","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/jc.2002-020890","volume":"88","author":"CC Chow","year":"2003","unstructured":"Chow CC et al. (2003) Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 88: 581\u2013587","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR78","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1210\/jc.2003-030908","volume":"89","author":"AA Kahn","year":"2004","unstructured":"Kahn AA et al. (2004) Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab 89: 3319\u20133325","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0265_CR79","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1210\/jc.2002-021597","volume":"88","author":"DM Shoback","year":"2003","unstructured":"Shoback DM et al. (2003) The calcimimetic AMG 073 normalizes serum calcium in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 88: 5644\u20135649","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"BFncpendmet0265_CR80","first-page":"S16","volume":"18","author":"M Peacock","year":"2003","unstructured":"Peacock M et al. (2003) Long term control of primary hyperparathyroidism with cinacalcet HCl. J Bone Miner Res 18 (Suppl 2): S16","journal-title":"J Bone Miner Res"},{"key":"BFncpendmet0265_CR81","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","volume":"21","author":"O Cope","year":"1966","unstructured":"Cope O (1966) The story of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med 21: 1174\u20131182","journal-title":"N Engl J Med"},{"key":"BFncpendmet0265_CR82","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00005792-197403000-00002","volume":"53","author":"LE Mallette","year":"1974","unstructured":"Mallette LE et al. (1974) Primary hyperparathyroidism: clinical and biochemical features. Medicine 53: 127\u201314655","journal-title":"Medicine"}],"container-title":["Nature Clinical Practice Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0265","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpendmet0265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:50:19Z","timestamp":1684439419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["BFncpendmet0265"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0265","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}